Cameco Q2 Sales $358.81M Beat $355.34M Estimate
Portfolio Pulse from Benzinga Newsdesk
Cameco (NYSE:CCJ) reported Q2 sales of $358.81 million, beating the analyst consensus estimate of $355.34 million by 0.98 percent. However, this represents a 17.94 percent decrease compared to the same period last year.
August 04, 2023 | 10:53 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Cameco's Q2 sales exceeded estimates, but are down 17.94% compared to last year. This mixed result could lead to uncertain market reactions.
Cameco's Q2 sales beat analyst estimates, which is generally a positive signal for the stock. However, the significant YoY decrease could be a concern for investors, potentially offsetting the positive impact of beating estimates. The net effect on the stock price is uncertain.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100